abstract |
The present invention relates to compositions and pharmaceutical compositions comprising poxviruses, in particular vaccinia virus such as modified vaccinia Ankara (MVA) virus, a sulfate salt at a concentration between about 5 mM and 300 mM and a buffer, wherein said composition has a pH of between about 6.0 and 8.5. It also discloses methods for stabilizing a poxvirus composition comprising preparing said viral formulation. |